Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-536CCB in Essential Hypertension
jRCT2080221586Phase 3
- Sponsor
- Takeda
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of azilsartan medoxomil + amlodipine in essential hypertension, sponsored by Takeda.
02
Drugs
azilsartan medoxomil + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT2080221586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221586.